Research and innovation in personalized medicine are surging. However, adoption of personalized medicine technologies into clinical practice is comparatively slow. This lag is causing the diagnostic and targeted therapeutic industries to focus on challenges that go beyond regulatory approval and reimbursement; involving clinical uptake of new technologies by healthcare providers.
Clinical adoption of new technologies often requires: improved awareness and education; a greater emphasis on patient perspectives; strong evidence of the value of molecular pathways in guiding care; new infrastructure and information management processes and reshaped healthcare delivery incentives. This session will discuss challenges to integrating personalized medicine into healthcare practice and discuss different strategies for addressing those challenges.
Session ID: 22293